Keli Walbert
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Keli Walbert is currently an Independent Director at Spruce Biosciences, Inc. since 2025.
Former positions include Independent Director at Apellis Pharmaceuticals, Inc. from 2025 to 2026, and Executive Vice President-US Commercial at Horizon Therapeutics Ltd. (Ireland) from 2019 to 2023.
Education includes graduate studies at Northwestern University and undergraduate studies at the University of Louisville.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director/Miembro de la Junta | 11/12/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 14/05/2026 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/01/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Louisville
University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spruce Biosciences, Inc.
Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.